Press release
RNA - based Therapeutics and Vaccines Market to Receive overwhelming hike in Revenues by 2016 - 2024
RNA plays a significant role in many biological processes thus it is considered to be a major target to develop advanced therapeutics and chemical genetic probe. In protein synthesis, RNA is a center figure that catalyzes reactions, encodes proteins, regulates gene expressions and plays another essential role in biological processes. RNA-based therapeutics and vaccines are a new class of treatment and precaution measure for a several rare and chronic diseases such as tuberculosis, cancer, diabetes, and cardiovascular condition. Ongoing research and development activities for the development of advanced biological drugs have widened the scope of therapeutic targets for a verity of diseases. This includes numerous RNA-based therapeutics under clinical trials for conditions such as genetic diseases and infectious diseases such as HIV-AIDS, as RNA controls human gene expression.To View full report @ http://www.persistencemarketresearch.com/market-research/rna-based-therapeutics-and-vaccines-market.asp
RNA-based therapeutics is mainly classified by its activity mechanism, and include inhibitors of mRNA translation (antisense), catalytically active RNA molecules (ribozymes), the agents of RNA interference (RNAi), and RNAs that bind protein and other molecular ligands (aptamers). RNAi was discovered in 1990 and termed post-transcriptional gene silencing as it works by turning off or silencing gene expression. Currently here are around 700 nucleic acid-based (DNA and RNA) therapeutics in the pipeline and around 60% of that are in preclinical development. Among these, 60% of pipeline products, 30% therapeutics are for the treatment of oncology. This technology has appeared to be dominant in the RNA-based therapeutics and vaccines market. Other technology such as RNA antisense, involves RNA strand synthesis, which binds to a specific mRNA in order to prevent translation. However, the issue of toxicity and drug delivery associated with RNA-based therapies is a significant challenge for commercialization. However, several new technologies have emerged to overcome these challenges, which will lead to the promising future of RNA-based therapeutics.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/12868
The global market for RNA-based therapeutics and vaccines is segmented on the basis of technology, application, indication, and end user:
By Technology
Small-interfering RNA (siRNA)
RNA interference (RNAi)
Micro RNA (miRNA)
Messenger RNA (mRNA)
By Application
Therapeutics
Diagnosis
Research and Development
Drug Discovery
By Indication
Infectious Diseases
Renal Diseases
Neurodegenerative Diseases
Respiratory Diseases
Cardiovascular diseases
Genetic Diseases
Others
By End User
Pharmaceutical Industry
Agriculture Industry
Clinical Research Organization
Other
The RNA-based therapeutics and vaccines market is be categorized based on technology, application, disease indications and end users. The technology segment is further segmented into mRNA, siRNA, miRNA and RNA interference. The application segment is further segmented into, diseases diagnosis, therapeutics, research & development, and drug discovery. Based on disease indication, the market is segmented into, cardiovascular, infectious, respiratory, neurodegenerative, genetic and renal diseases. In this market, infectious disease segment is expected to witness highest growth rate during the forecast period due to growing incidence of AIDS and Hepatitis B. Based on the end user; the market is segmented into the pharmaceutical industry, agriculture industry, clinical research organization and other. Presently, research institutes primarily utilize RNA technology for the development of RNA drugs, thereby accounting for the largest market share.
Buy Now: You can now buy a single user license of the report @ http://www.persistencemarketresearch.com/checkout/12868
On the basis of region presence, RNA-based therapeutics and vaccines market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. Currently, North America dominates the global market for RNA-based therapeutics and vaccines followed by Europe, owing to the high adoption of advanced technologies for drug discovery and development. Further, the rising number of cancer patients and increasing diagnosis rate of infectious diseases and increase in the prevalence of the neurodegenerative and cardiovascular disease is expected to fuel the RNA-based therapeutics and vaccines market. Moreover, a substantial investment in research and development, availability of high-end infrastructure for the development and growing government support of RNA are few of the factors responsible for the market growth. RNA-based therapeutics and vaccines market in Asia-Pacific and the Middle East and Africa is expected to register high growth due to developing healthcare infrastructure and high prevalence of infectious diseases
Some of the major market players in RNA-based therapeutics and vaccines market globally include Sanofi S.A, Atlantic Pharmaceuticals Inc., GlaxoSmithKline plc, Novartis AG, AstraZeneca plc., Isis Pharmaceuticals, Bristol-Myers Squibb, Alnylam Pharmaceuticals Inc. Quark Pharmaceuticals, Inc, Silence Therapeutics PLC. The market is currently witnessing a number of strategic collaboration and partnership activities by pharmaceutical and biotechnology companies.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA - based Therapeutics and Vaccines Market to Receive overwhelming hike in Revenues by 2016 - 2024 here
News-ID: 667615 • Views: …
More Releases from Persistence Market Research

Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…

Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…

US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…

Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…